BPC 157 can enhance the expression and endocytosis of VEGFR2, and subsequently the phosphorylation of AKT and eNOS as proved in our previous study 6
We never compromise on quality because your body deserves only the best
If you are going to do this, you will experience some serious side effects from an overdose
doi: 10.1158/1538-7445.AM2017-1279 108 Martnez-RizoAGonzlez-CordovaBPea-GeorgeC(CA-UAN-266) CA de IBNavarro-PartidaJGonzlez-CarrilloMet al
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry